Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient‐Derived Xenograft Assays

Hepatology(2020)10.1002/hep.31096Source: DataRank Database

Uncovering Biological Factors That Regulate Hepatocellular Carcinoma Growth Using Patient‐Derived Xenograft Assays is a research paper published in Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.05)OA: bronzeTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Lin Li ORCID,Tianshi Lu ORCID,Hyesun Yoo,Ji Zhu ORCID,Purva Gopal ORCID

Live enrichment

PubMed:31899548 PMC:PMC7332388 OpenAlex:https://openalex.org/W2997410760

NIMHD NIH HHS

Grant: R01 MD012565

Defense Health Agency

Grant: W81XWH‐16‐1‐0158

NCI NIH HHS

Grant: K08 CA222611

NCI NIH HHS

Grant: R01 MD12565

FWCI

2.05

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: http://doi.wiley.com/10.1002/tdm_license_1.1

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.31096

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.31096

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.31096

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31096

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/hep.31096

Fields of Study

Hepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathologyCancer Cells and MetastasisAnimalsAntineoplastic AgentsBiopsyCarcinoma, HepatocellularFemaleGene ExpressionHepatectomyHumansLiverLiver NeoplasmsMaleMiceMiddle AgedNeoplasm StagingTumor MicroenvironmentXenograft Model Antitumor Assays

MeSH Terms

AnimalsAntineoplastic AgentsBiopsyFemaleHepatectomyCarcinoma, HepatocellularHumansLiverLiver NeoplasmsMaleMiddle AgedNeoplasm StagingGene ExpressionXenograft Model Antitumor AssaysMiceTumor Microenvironment

Keywords

HCCSHepatocellular carcinomaSorafenibRegorafenibCancer researchMedicineBiologyPathologyInternal medicineCancerColorectal cancer

Sustainable Development Goals

SDG 0: Good health and well-being